Physician

Liliya Golas, MD

According to 2025 Medicare claims, Liliya Golas, MD (NPI: 1346509205) practices ophthalmology in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Sacramento, CA. This provider's primary affiliated billing organization is LILIYA GOLAS MD INC (NPI: 1043798218; TIN: 831203500) and primary practice location at 95670-2862.

Golas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 730 traditional Medicare patients, billed 15,582 HCPCS/CPT codes, and received $926,106 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,243 prescription claims across 464 beneficiaries totaling $362,039 in drug costs, led by Cyclosporine (Cyclosporine). Open Payments data shows 65 records totaling $873,539. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $53,035 to $926,106. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,341 to $362,039. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$463K$926K2018 Medicare payment: $53,035 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $278,029 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $197,481 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $329,551 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $379,898 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $672,685 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $926,106 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018183541$53,035
20197123,337$278,029
20204832,260$197,481
20215252,963$329,551
20225603,195$379,898
202361410,201$672,685
202473015,582$926,106

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$208K$416K2015 Drug cost: $2,341 (USD; Tot_Drug_Cst)2016 Drug cost: $1,491 (USD; Tot_Drug_Cst)2017 Drug cost: $6,810 (USD; Tot_Drug_Cst)2018 Drug cost: $18,489 (USD; Tot_Drug_Cst)2019 Drug cost: $155,527 (USD; Tot_Drug_Cst)2020 Drug cost: $236,746 (USD; Tot_Drug_Cst)2021 Drug cost: $307,984 (USD; Tot_Drug_Cst)2022 Drug cost: $345,223 (USD; Tot_Drug_Cst)2023 Drug cost: $415,585 (USD; Tot_Drug_Cst)2024 Drug cost: $362,039 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153070$2,341
2016N/R19$1,491
20172475$6,810
201870150$18,489
20193071,210$155,527
20203141,582$236,746
20213581,716$307,984
20223761,730$345,223
20234182,021$415,585
20244642,243$362,039

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more333620$107
67028Injection of drug into eye122525$100
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more357540$45
92134Imaging of retina575900$34
92250Photography of the retina242253$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CyclosporineCyclosporine1629,330$71,024
XiidraLifitegrast472,130$47,447
RestasisCyclosporine291,800$36,627
LumiganBimatoprost613,790$34,050
TyrvayaVarenicline Tartrate331,290$28,138

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.61$3,004ARGENX US, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.4$870,535Novartis Pharmaceuticals Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Liliya Golas, MD?

Tedicare shows public-source Medicare data for Liliya Golas, MD (NPI 1346509205), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Liliya Golas, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Liliya Golas, MD?

Liliya Golas, MD is linked to LILIYA GOLAS MD INC (billing NPI 1043798218) in the available physician profile data.

Does Liliya Golas, MD have Open Payments data?

Liliya Golas, MD has 65 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.